Avalo Therapeutics (AVTX) Stock Chart & Stock Price History $14.28 +0.38 (+2.70%) As of 12:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avalo Therapeutics Stock Price Performance The Avalo Therapeutics (AVTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 38.73%, with a year-to-date return of 92.13%. In the past month, the stock has increased 46.26%, reflecting recent market activity. As of the latest close, Avalo Therapeutics traded at $13.90 with a market cap of $182.81 million and volume of 187,261 shares. Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.33%1 Month Performance+46.26%3 Month Performance+194.33%Year-To-Date Performance+92.13%1 Year Performance+38.73% AVTX Stock Chart for Thursday, October, 16, 2025 AVTX Chart by TradingView Avalo Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$13.99$13.90-0.64%$14.28$13.42187,261 shs$182.81 million10/14/2025$13.67$13.99+2.34%$14.24$13.37169,313 shs$183.97 million10/13/2025$13.95$13.67-2.01%$14.48$13.20273,875 shs$179.76 million10/10/2025$14.97$13.95-6.81%$14.91$13.82240,127 shs$183.44 million10/09/2025$14.22$14.97+5.27%$15.71$14.24622,740 shs$196.89 million10/08/2025$13.48$14.22+5.49%$15.99$13.48399,666 shs$186.99 million10/07/2025$14.00$13.48-3.71%$14.30$13.40225,789 shs$177.26 million10/06/2025$13.40$14.00+4.48%$14.73$13.43315,041 shs$184.13 million10/03/2025$13.00$13.40+3.08%$13.60$12.84312,271 shs$176.24 million10/02/2025$12.96$13.00+0.31%$13.35$12.41275,178 shs$170.95 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$12.71$12.96+1.97%$14.18$12.71557,645 shs$170.42 million09/30/2025$13.02$12.71-2.38%$13.29$12.61494,099 shs$167.16 million09/29/2025$10.80$13.02+20.56%$14.07$12.503.06 million shs$171.21 million09/26/2025$11.55$10.80-6.49%$12.00$10.70304,634 shs$142.02 million09/25/2025$11.60$11.55-0.43%$12.20$11.12240,414 shs$151.88 million09/24/2025$11.25$11.60+3.11%$11.80$11.18222,299 shs$152.54 million09/23/2025$11.70$11.25-3.85%$11.83$10.97226,701 shs$147.94 million09/22/2025$11.83$11.70-1.10%$11.84$11.25262,019 shs$153.86 million09/19/2025$11.88$11.83-0.42%$11.90$11.50322,271 shs$155.56 million09/18/2025$11.33$11.88+4.85%$12.09$11.25558,537 shs$156.22 million09/17/2025$9.76$11.33+16.09%$11.76$9.84928,028 shs$128.36 million09/16/2025$10.14$9.76-3.75%$10.33$9.54294,315 shs$128.34 million09/15/2025$10.65$10.14-4.79%$11.16$9.97187,343 shs$133.34 million Related Companies Erasca Stock Chart GH Research Stock Chart MeiraGTx Stock Chart SNDL Stock Chart Esperion Therapeutics Stock Chart Keros Therapeutics Stock Chart Siga Technologies Stock Chart Inventiva Stock Chart COMPASS Pathways Stock Chart Monopar Therapeutics Stock Chart Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTX) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...Huge Alerts | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThe Final DisplacementA new documentary called The Final Displacement is stirring major controversy — and for good reason. It expose...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
